Ohio State Navbar


Drug Shows Potential as Safe and Effective for Chronic Leukemia, Mantle Cell Lymphoma

June 20, 2013

Drug shows surprising efficacy as treatment for chronic leukemia, mantle cell lymphoma The rest of the story

Congratulations to Dr. Leslie Andritsos and Dr. Don Benson

May 23, 2013

Excellence in Teaching Awards 2013- from Student Programs The rest of the story

Dr. Robert Baiocchi Merging Innovations with Commercialization

April 23, 2013

Dr. Robert Baiocchi Merging Innovations with Commercialization The rest of the story

Byrd Receives Freireich Award for Clinical Cancer Research

April 10, 2013

John Byrd, MD, director of the Division of Hematology with the OSUCCC – James, received the Emil J. Freireich Award for clinical cancer research The rest of the story

Frontiers' Highlight - John C. Byrd, MD

February 11, 2013

AUSPICIOUS AGENT Experimental Drug Ibrutinib Highly Active in CLL Patients The rest of the story

Frontiers' Highlight - Jennifer Woyach, MD

February 11, 2013

AGE ANALYSIS Older and Younger Chronic Leukemia Patients May Need Different Therapy The rest of the story

Frontiers' Highlight - Steven Devine, MD

February 11, 2013

LESS IS MORE Reduced-Intensity Regimen Before BMT is Better for Older Leukemia Patients The rest of the story

Dec. 8: Ohio State’s 2012 Scarlet and Gray Reception at the

December 06, 2012

We look forward to meeting and collaborating with our colleagues during the 2012 ASH Annual Meeting and Exposition in Atlanta and seeing everyone at our reception on Saturday, Dec. 8, at the Omni Hotel at CNN Center, International Ballroom, 100 CNN Center, from 7:30-9:30 p.m. To RSVP, please click here. Questions? Contact Katie Jones at Katie.Jones@osumc.edu or (614) 366-5183. The rest of the story

Ohio State Lymphoma Specialist Elected to Prominent Scientific Advisory Board

December 06, 2012

Kristie Blum, MD, an associate professor and co-director of the Lymphoma Program in the Department of Internal Medicine’s Division of Hematology at Ohio State, has been elected to the Scientific Advisory Board for the Lymphoma Research Foundation. Read more: The rest of the story

Pelotonia 12 Brings 4-Year Total to More Tham $42 Million

December 06, 2012

Pelotonia, the fourth installment of an annual grassroots bicycle tour that raises millions of dollars for cancer research at the OSUCCC – James, has raised more than $42 million in the four years since it began in 2009. Riders and donors in Pelotonia 12 raised a record $16.8 million, a 28-percent increase over the Pelotonia 11 total of $13.1 million. Pelotonia 12, which took place Aug. 10-12 on routes between Columbus and Kenyon College in Gambier, Ohio, drew a record 6,212 riders, as well as 3,141 virtual riders and more than 2,000 volunteers. Thanks to the generosity of a few truly committed community sponsors who underwrite the costs of Pelotonia, 100% of every dollar raised by riders and donors goes directly to fund cancer research at Ohio State. The rest of the story

Previous     Next